Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar foolfully (60.94) Submitted: 11/21/2012 4:15:10 PM : Outperform Start Price: $39.69 CBST Score: +43.09

100

Featured Broker Partners


Advertisement